Delivery Order SPE2DB24D1201-SPE2DB25FJCTF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,944.08 to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 100 mg, a prescription opioid medication used for pain management. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of July 15, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,013.96 to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 150 mg, an extended-release opioid pain medication. This non-set-aside, competitively awarded delivery order carries a firm fixed price and is scheduled for completion by August 25, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,761.86 to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 200 mg, a prescription opioid pain medication. The contract, executed on July 28, 2025, with an ultimate completion date of July 29, 2025, employs firm fixed-price pricing with no set-aside designation, indicating competitive award status. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,810.39 for 60-count tablets of Nucynta ER 50 mg, an opioid pain management medication. Issued on September 4, 2025, with an ultimate completion date of September 5, 2025, this firm fixed-price delivery order represents a non-competitive award under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract will be performed at the vendor's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $3,914.75 to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 100 mg, a controlled-release pain management pharmaceutical. This contract type delivery order carries firm fixed pricing and was competitively awarded with no set-aside designation. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 17, 2025. This delivery order represents a...
- The Defense Logistics Agency awarded a $2,928.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 200 mg, a prescription opioid pain management medication. The contract, awarded on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a non-competitive set-aside delivery order under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $5,670.65 to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 100 mg, an extended-release opioid pain medication. This non-set-aside, firm fixed-price delivery order was awarded on August 29, 2025, with an ultimate completion date of September 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Nucynta ER Tabs 100mg, a prescription opioid pain management medication. This firm fixed-price delivery order, valued at $9,992.08, represents a competitive award with no set-aside designation and is scheduled for completion by July 17, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $1,194.33 to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 50 mg, a controlled-release pain management pharmaceutical. The contract was competitively awarded without set-aside provisions under a firm fixed price arrangement, with performance scheduled for completion by June 4, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this medical supply delivery....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 200 mg, a prescription opioid pain management medication, with a contract ceiling value of $2,411.52. This is a firm fixed-price delivery order issued on August 6, 2025, with an ultimate completion date of August 7, 2025, with no set-aside designation. The place of performance is the company's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a...
- SPE2DB24D1201Indefinite Delivery Contract
- SPE2DB24D1201-SPE2DB25FJCTFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,531.10 to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 150 mg, a prescription opioid pain management medication. The award, made on May 20, 2025, with completion targeted for May 21, 2025, utilized firm fixed price contracting with no set-aside designation, indicating competitive award procedures. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen maintains an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies supporting military and veteran healthcare systems. The parent IDC functions as a flexible contracting mechanism enabling the company to fulfill diverse pharmaceutical requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 5/20/25 |